Pharmer.org

Reuters - Pharmaceutical companies need to be more responsible in touting products to consumers or else face tighter controls from Congress, a top U.S. Democratic lawmaker said on Thursday.

Reuters - Pharmaceutical companies need to be more responsible in touting their products to consumers or else face tighter controls from Congress, a top U.S. Democratic lawmaker said on Thursday.

Reuters - CVS Caremark Corp posted higher quarterly profits in line with analysts' estimates on Thursday, as the addition of Caremark's pharmacy benefits business helped offset the impact of lower-priced generic drugs on drugstore sales.

Reuters - Stocks ended little changed on Tuesday as setbacks for two drugs weighed down the pharmaceutical sector, offsetting the relief from a retreat in record high crude oil prices.

AFP - The US Food and Drug Administration on Monday said a new cholesterol drug being tested by Merck was not approvable, while the pharmaceutical giant vowed to press ahead with the application.

AFP - US pharmaceuticals company Pfizer Inc. and the Nigerian state of Kano resumed talks aimed at reaching an out-of-court settlement over an alleged illegal drugs trial, an official said Monday.

AFP - British pharmaceutical giant GlaxoSmithKline said on Wednesday that first-quarter net profits tumbled, partly because of sliding sales of diabetes drug Avandia.

Reuters - Tight cost controls helped Merck & Co and Swiss drugmaker Novartis AG to better-than-expected quarterly earnings on Monday, while high expenses contributed to disappointing results from Eli Lilly and Co .

Reuters - Merck & Co on Monday reported better-than-expected quarterly earnings as tight cost controls offset plunging sales of an osteoporosis drug now facing generic competition and slowing sales growth of its Vytorin and Zetia cholesterol fighters.

Reuters - Eli Lilly and Co on Monday posted lower-than-expected quarterly earnings, as disappointing sales of its Byetta diabetes drug overshadowed growing demand for its other medicines, sending shares 3.4 percent lower.